| Serial Number | 79358612 |
| Word Mark | NUACRES |
| Filing Date | Monday, November 7, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 6, 2025 |
| Registration Number | 7781043 |
| Registration Date | Tuesday, May 6, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 18, 2025 |
| Goods and Services | Medical treatments, particularly in the field of oncology and infectiology; medical analysis services related to the treatment of patients, particularly in the field of oncology and infectiology; medical services in connection with the treatment of cancer; medical testing in connection with the diagnosis and treatment of diseases, particularly in the field of oncology and infectiology; medical testing for diagnostic or treatment purposes, particularly in the field of oncology and infectiology; medical treatments based on clinical treatment algorithms, particularly in the field of oncology and infectiology; performance of medical tests related to the diagnosis and treatment of cancer; medical examinations for the diagnosis or treatment of cancer; medical treatments of cancer based on clinical treatment algorithms; medical equipment rental, particularly for computer aided treatments; medical services; pharmaceutical services, namely, monitoring of drug therapy used for cancer and infectious diseases for medical treatment and diagnosis purposes; computer-assisted medical assessment and diagnostical services |
| Goods and Services | Technical services relating to pharmaceutical and medical preparations, pharmaceuticals and drugs, namely, technical research in the field of using computers to diagnose disease and health conditions; provision of information relating to medical and veterinary research and development, particularly in the field of oncology and infectiology; providing an on-line searchable database in the fields of medical and veterinary research and development, particularly in the field of oncology and infectiology; research and development for the pharmaceutical industry, particularly in the field of oncology and infectiology; biomedical research services; research and development services in the field of oncology; research and development services in the field of infectiology; research and development of biomolecules, cells and cellular products for medical use; research and development of biomedical products, particularly therapeutical and prophylactic substances for medical use in the field of oncology and infectiology; research and development in the field of clinical treatment algorithms; medical laboratory services; computer diagnostic services, particularly based on clinical treatment algorithms; computer diagnostic services, particularly in the field of oncology; computer diagnostic services, particularly in the field of infectiology; development of diagnostic apparatus for computer aided medical treatment |
| Goods and Services | Medical and veterinary preparations for the treatment of neoplastic pathologies and infectious diseases; pharmaceuticals, namely, vaccines; biomedical pharmaceutical products for the treatment of neoplastic pathologies and infectious diseases; clinical diagnostic reagents for medical use; therapeutical agent substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); Prophylactical agent substances in the nature of infection prophylactic agents and cancer prophylactic agents; pharmaceutical products, particularly for the field of oncology and infectiology all in the nature of pharmaceutical products for the prevention and treatment of cancer and infectious diseases; biomedical products based on cytological research substances all in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); pharmaceuticals, particularly for the use in algorithm supported medical treatment all in the nature of pharmaceuticals for treating of infectious diseases and cancer; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleotids and nucleic acid antibodies (aptamers) and reagents as part of medical and veterinary preparations; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for the treatment of cancer and infectious diseases and reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparations |
| Goods and Services | Chemical or biological substances in the nature of Oligo- and poly-nucleotide arrays for scientific and medical research and reagents for scientific purposes; Chemical or biological substances, namely, molecular constructs made of DNA or RNA to serve as reagents for research in the field of diagnostics; Chemical or biological molecular constructs made of DNA or RNA for scientific or medical research use; Chemicals and chemical preparations for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 27, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 27, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 27, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 27, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nucleic Acids to the Rescue GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | DE |
| Party Name | Nucleic Acids to the Rescue GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | DE |
| Party Name | Nucleic Acids to the Rescue GmbH |
| Party Type | 12 - New Owner Before Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | DE |
| Party Name | Gentechnologiestiftung - |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 12 - Foundation |
| Address | DE |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Event Date | Event Description |
| Friday, December 23, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, December 27, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 31, 2022 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 22, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, September 6, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, September 7, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 25, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, September 25, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, October 17, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, March 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, April 19, 2024 | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST |
| Monday, April 29, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, June 7, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Friday, June 7, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, June 14, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Friday, June 21, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Sunday, June 30, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, February 25, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 25, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 12, 2025 | NOTICE OF PUBLICATION |
| Tuesday, March 18, 2025 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 19, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, March 19, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, March 19, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, March 19, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, March 19, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 6, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 6, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, August 6, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, November 26, 2025 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 26, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, December 11, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |